All Stories

  1. Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4/CD8 Ratio in Treatment-Naive HIV-Infected Individuals

    Article • Antimicrobial Agents and Chemotherapy, October 2017, ASM Journals

    Sergio Serrano-Villar

  2. How can the gut microbiota affect immune recovery in HIV-infected individuals?

    Article • Future Microbiology, March 2017, Future Medicine

    Sergio Serrano-Villar

  3. HIV, HPV, and microbiota

    Article • AIDS, February 2017, Wolters Kluwer Health

    Sergio Serrano-Villar

  4. Beyond Undetectable Viral Load: Effect of Nucleotides on Inflammation

    Article • EBioMedicine, November 2016, Elsevier

    Sergio Serrano-Villar

  5. Different impact of raltegravir versus efavirenz on CD4/CD8 ratio recovery in HIV-infected patients

    Article • Journal of Antimicrobial Chemotherapy, September 2016, Oxford University Press (OUP)

    Sergio Serrano-Villar

  6. Prevalence of Elevated Blood Pressure in HIV-infected Children, Adolescents and Young Adults

    Article • The Pediatric Infectious Disease Journal, July 2016, Wolters Kluwer Health

    Sergio Serrano-Villar

  7. Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy

    Article • AIDS, June 2016, Wolters Kluwer Health

    Sergio Serrano-Villar

  8. Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions

    Article • Open Forum Infectious Diseases, April 2016, Oxford University Press (OUP)

    Sergio Serrano-Villar

  9. Respuesta

    Article • Medicina Clínica, March 2015, Elsevier

    Sergio Serrano-Villar

  10. Reply

    Article • Medicina Clínica (English Edition), March 2015, Elsevier

    Sergio Serrano-Villar

  11. CD4/CD8 ratio: an emerging biomarker for HIV

    Article • The Lancet HIV, March 2015, Elsevier

    Sergio Serrano-Villar

  12. Monitoring the CD4/CD8 ratio: a promising indicator of disease progression in HIV-infected individuals?

    Article • Future Virology, January 2015, Future Medicine

    Sergio Serrano-Villar

  13. Infections caused by carbapenemase-producing Enterobacteriaceae: Risk factors, clinical features and prognosis

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2014, Elsevier

    Sergio Serrano-Villar

  14. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery

    Article • HIV Medicine, September 2013, Wiley

    Sergio Serrano-Villar

  15. Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment

    Article • AIDS, August 2013, Wolters Kluwer Health

    Dr Alejandro Vallejo, Sergio Serrano-Villar

  16. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults

    Article • AIDS, June 2013, Wolters Kluwer Health

    Sergio Serrano-Villar

  17. Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections

    Article • Clinical Infectious Diseases, April 2013, Oxford University Press (OUP)

    Sergio Serrano-Villar

  18. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression

    Article • Journal of Infection, January 2013, Elsevier

    Dr Alejandro Vallejo, Sergio Serrano-Villar

  19. Authors′ Reply

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2013, Wolters Kluwer Health

    Sergio Serrano-Villar

  20. El ictus en pacientes muy ancianos: mitos y realidades

    Article • Medicina Clínica, January 2013, Elsevier

    Sergio Serrano-Villar

  21. Association of HIV-Infection and Antiretroviral Therapy With Levels of Endothelial Progenitor Cells and Subclinical Atherosclerosis

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2012, Wolters Kluwer Health

    Sergio Serrano-Villar

  22. The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis

    Article • Pathogens and Global Health, November 2012, Taylor & Francis

    Sergio Serrano-Villar

  23. Factores clínicos y biomarcadores asociados a lesión vascular subclínica en la infección por el virus de la inmunodeficiencia humana

    Article • Medicina Clínica, September 2012, Elsevier

    Sergio Serrano-Villar

  24. Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected Patients

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, February 2012, Wolters Kluwer Health

    Sergio Serrano-Villar

  25. Interacciones medicamentosas de etravirina

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2009, Elsevier

    Sergio Serrano-Villar

  26. P0007 STROKE IN THE VERY OLD

    Article • European Journal of Internal Medicine, May 2009, Elsevier

    Sergio Serrano-Villar

  27. P0398 ACUTE ISCHEMIC STROKE: A STUDY OF EPIDEMIOLOGICAL CHARACTERISTICS

    Article • European Journal of Internal Medicine, May 2009, Elsevier

    Sergio Serrano-Villar

  28. P0680 CARDIOVASCULAR RISK IN HIV INFECTION

    Article • European Journal of Internal Medicine, May 2009, Elsevier

    Sergio Serrano-Villar

  29. Commentary: Patient's view

    Article • BMJ, March 2009, BMJ

    Sergio Serrano-Villar